Turn Therapeutics Inc (TTRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access TTRX quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Turn Therapeutics Inc balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
Assets
Cash & cash equivalent5.08
Security Deposit0.01
Cash & Short-term Investments5.00
Prepaid Expense And Other Assets Current0.12
Total Current Assets5.21
Intangible Assets0.92
Deferred Costs, Noncurrent AS5.96
Other Assets, Noncurrent0.08
Operating Lease Right Of Use Asset0.08
Total Assets12.16
Liabilities
Accounts Payable and Other Accrued Liabilities, Current2.93
Derivative Liability, Current DE3.03
Other Liabilities, Current0.05
Total Current Liabilities6.00
Total Long-term Debt0.00
Other liabilities, Noncurrent1.47
ContractWithCustomerLiabilityNoncurrent1.44
Operating Lease Liability Current0.05
Total Liabilities7.48
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock28.14
Retained Earnings / Accumulated Deficit-22.39
Other Equity-1.07
Common Stockholder's Equity4.69
Total Stockholder's Equity4.69
Liabilities & Stockholder's Equity12.16
4 historic quarters locked

Sign in to unlock the full Turn Therapeutics Inc balance sheet history.

About Turn Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-037505

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License